Brief: Biorestorative Therapies To Seek FDA Approval To Expand The Clinical Application Of BRTX-100
13/03/2023 11:47
March 13 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES TO SEEK FDA APPROVAL TO EXPAND
THE
CLINICAL APPLICATION OF BRTX-100
Source text for Eikon: ID:nGNX7dhZ9g
Further company coverage: BRTX.O
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM